Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  FUJIFILM Holdings Corporation    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fujifilm : applies for approval of Avigan as COVID-19 treatment in Japan

10/15/2020 | 10:06pm EST

TOKYO, Oct 16 (Reuters) - Fujifilm Holdings Corp said on Friday it had applied for approval in Japan of its anti-influenza drug Avigan as a treatment for COVID-19.

The company had said in September a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month. (Reporting by Chris Gallagher; Editing by Muralikumar Anantharaman)


© Reuters 2020
All news about FUJIFILM HOLDINGS CORPORATION
11/13FUJIFILM : Cellular Dynamics and Lonza Agree to Expand the Availability and Use ..
AQ
11/05WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remd..
RE
11/05FUJIFILM HOLDINGS CORPORATION : half-yearly earnings release
10/30In Japan's Nagasaki, some glimmers of economic revival
RE
10/22FUJIFILM : Fuji Xerox in court over alleged unfair contract terms
AQ
10/22Dr Reddy's isolates data center services after cyberattack
RE
10/22Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan
RE
10/21Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan
RE
10/19Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
RE
10/16Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
RE
More news
Financials
Sales 2021 2 200 B 21 132 M 21 132 M
Net income 2021 127 B 1 220 M 1 220 M
Net Debt 2021 170 B 1 630 M 1 630 M
P/E ratio 2021 17,9x
Yield 2021 1,68%
Capitalization 2 291 B 22 022 M 22 006 M
EV / Sales 2021 1,12x
EV / Sales 2022 1,05x
Nbr of Employees 73 906
Free-Float 73,8%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 6 164,67 JPY
Last Close Price 5 730,00 JPY
Spread / Highest target 20,4%
Spread / Average Target 7,59%
Spread / Lowest Target -12,4%
EPS Revisions
Managers
NameTitle
Shigetaka Komori Chairman & Group Chief Executive Officer
Kenji Sukeno President, Group COO & Representative Director
Takashi Iwasaki Director & Chief Technology Officer
Kouichi Tamai Director & Vice President
Takatoshi Ishikawa Director
Sector and Competitors
1st jan.Capitalization (M$)
FUJIFILM HOLDINGS CORPORATION10.06%22 068
CANON INC.-34.89%19 503
BROTHER INDUSTRIES, LTD.-8.37%5 186
RICOH COMPANY, LTD.-39.60%5 002
TOSHIBA TEC CORPORATION-12.94%2 076
KONICA MINOLTA, INC.-52.31%1 616